| Year |
Citation |
Score |
| 2014 |
Yan F, Alinari L, Lustberg ME, Martin LK, Cordero-Nieves HM, Banasavadi-Siddegowda Y, Virk S, Barnholtz-Sloan J, Bell EH, Wojton J, Jacob NK, Chakravarti A, Nowicki MO, Wu X, Lapalombella R, ... ... Haseley A, et al. Genetic validation of the protein arginine methyltransferase PRMT5 as a candidate therapeutic target in glioblastoma. Cancer Research. 74: 1752-65. PMID 24453002 DOI: 10.1158/0008-5472.Can-13-0884 |
0.716 |
|
| 2013 |
Okemoto K, Kasai K, Wagner B, Haseley A, Meisen H, Bolyard C, Mo X, Wehr A, Lehman A, Fernandez S, Kaur B, Chiocca EA. DNA demethylating agents synergize with oncolytic HSV1 against malignant gliomas. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 19: 5952-9. PMID 24056786 DOI: 10.1158/1078-0432.CCR-12-3588 |
0.704 |
|
| 2013 |
Okemoto K, Wagner B, Meisen H, Haseley A, Kaur B, Chiocca EA. STAT3 activation promotes oncolytic HSV1 replication in glioma cells. Plos One. 8: e71932. PMID 23936533 DOI: 10.1371/Journal.Pone.0071932 |
0.735 |
|
| 2013 |
Currier MA, Eshun FK, Sholl A, Chernoguz A, Crawford K, Divanovic S, Boon L, Goins WF, Frischer JS, Collins MH, Leddon JL, Baird WH, Haseley A, Streby KA, Wang PY, et al. VEGF blockade enables oncolytic cancer virotherapy in part by modulating intratumoral myeloid cells. Molecular Therapy : the Journal of the American Society of Gene Therapy. 21: 1014-23. PMID 23481323 DOI: 10.1038/Mt.2013.39 |
0.602 |
|
| 2013 |
Uchida H, Marzulli M, Nakano K, Goins WF, Chan J, Hong CS, Mazzacurati L, Yoo JY, Haseley A, Nakashima H, Baek H, Kwon H, Kumagai I, Kuroki M, Kaur B, et al. Effective treatment of an orthotopic xenograft model of human glioblastoma using an EGFR-retargeted oncolytic herpes simplex virus. Molecular Therapy : the Journal of the American Society of Gene Therapy. 21: 561-9. PMID 23070115 DOI: 10.1038/Mt.2012.211 |
0.776 |
|
| 2012 |
Yoo JY, Pradarelli J, Haseley A, Wojton J, Kaka A, Bratasz A, Alvarez-Breckenridge CA, Yu JG, Powell K, Mazar AP, Teknos TN, Chiocca EA, Glorioso JC, Old M, Kaur B. Copper chelation enhances antitumor efficacy and systemic delivery of oncolytic HSV. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 18: 4931-41. PMID 22753591 DOI: 10.1158/1078-0432.Ccr-12-0697 |
0.694 |
|
| 2012 |
Haseley A, Boone S, Wojton J, Yu L, Yoo JY, Yu J, Kurozumi K, Glorioso JC, Caligiuri MA, Kaur B. Extracellular matrix protein CCN1 limits oncolytic efficacy in glioma. Cancer Research. 72: 1353-62. PMID 22282654 DOI: 10.1158/0008-5472.Can-11-2526 |
0.719 |
|
| 2012 |
Yoo JY, Haseley A, Bratasz A, Chiocca EA, Zhang J, Powell K, Kaur B. Antitumor efficacy of 34.5ENVE: a transcriptionally retargeted and "Vstat120"-expressing oncolytic virus. Molecular Therapy : the Journal of the American Society of Gene Therapy. 20: 287-97. PMID 22031239 DOI: 10.1038/Mt.2011.208 |
0.763 |
|
| 2012 |
Okemoto K, Wagner BP, Haseley AM, Price RL, Kaur B, Chiocca AE. Abstract 4080: 5-Azacitydine augments the anti-glioma efficacy of Herpes-based oncolytic virotherapy Cancer Research. 72: 4080-4080. DOI: 10.1158/1538-7445.Am2012-4080 |
0.571 |
|
| 2010 |
Haseley A, Boone S, Kurozumi K, Kaur B. Abstract 1505: The effect of Cyr61 on oncolytic HSV-1 therapy for glioblastoma multiforme Cancer Research. 70: 1505-1505. DOI: 10.1158/1538-7445.Am10-1505 |
0.701 |
|
| 2009 |
Haseley A, Alvarez-Breckenridge C, Chaudhury AR, Kaur B. Advances in oncolytic virus therapy for glioma. Recent Patents On Cns Drug Discovery. 4: 1-13. PMID 19149710 DOI: 10.2174/157488909787002573 |
0.795 |
|
| Show low-probability matches. |